Mutational Analysis of Fukutin Gene in Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy

被引:15
|
作者
Arimura, Takuro
Hayashi, Yukiko K. [2 ]
Murakami, Terumi [2 ]
Oya, Yasushi [3 ]
Funabe, Sayaka
Arikawa-Hirasawa, Eri
Hattori, Nobutaka
Nishino, Ichizo [2 ]
Kimura, Akinori [1 ,4 ]
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Bunkyo Ku, Tokyo 1138510, Japan
[2] Juntendo Univ, Sch Med, Dept Neuromuscular Res, Natl Inst Neurosci,NCNP, Tokyo 113, Japan
[3] Juntendo Univ, Sch Med, Dept Neurol, Natl Ctr Hosp Neurol & Psychiat,NCNP, Tokyo 113, Japan
[4] Tokyo Med & Dent Univ, Sch Biomed Sci, Lab Genome Divers, Tokyo 1138510, Japan
基金
日本学术振兴会;
关键词
Cardiomyopathy; Genes; Genetics; Muscles; CONGENITAL MUSCULAR-DYSTROPHY; FUKUYAMA-TYPE; RETROTRANSPOSAL INSERTION; JAPANESE; TITIN; PATIENT; FCMD;
D O I
10.1253/circj.CJ-08-0722
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mutations in FKTN encoding for fukutin cause Fukuyama-type congenital muscular dystrophy characterized by severe muscle wasting and hypotonia with mental retardation. Fukuyama-type congenital muscular dystrophy is a recessive genetic trait. FKTN mutations in patients with dilated cardiomyopathy (DCM) have been investigated by our research group. The patients showed hyper-CKemia with mild or no muscle weakness and without mental retardation, suggesting that the clinical spectrum of FKTN mutations are wider than previously thought. The current study was designed to further explore the association of FKTN mutations with DCM or hypertrophic cardiomyopathy (HCM). Methods and Results A total of 172 patients with DCM, 144 patients with familial HCM and 384 control individuals were analyzed for FKTN mutations. There was a DCM patient who was a compound heterozygote of a 3-kb insertion mutation and a missense mutation Cys 101 Phe. The patient showed hyper-CKemia with mild muscle involvement and no brain involvement. In contrast, 2 other DCM patients and 3 controls were heterozygous for the insertion mutation and normal allele, showing that the heterozygous insertion mutation itself was not associated with DCM. No Mutation was found in the HCM patients. Conclusions These observations indicated that the compound heterozygous FKTN mutation was a rare cause of DCM. Hyper-CKemia might be indicative of FKTN mutation in DCM. (Circ J 2009; 73: 158 - 161)
引用
收藏
页码:158 / 161
页数:4
相关论文
共 50 条
  • [41] Stress-echocardiography in hypertrophic and dilated cardiomyopathy
    Duplyakov, D. V.
    KARDIOLOGIYA, 2007, 47 (07) : 68 - 71
  • [42] Clinical and genetic aspects of hypertrophic and dilated cardiomyopathy
    Meder, B.
    Katus, H. A.
    INTERNIST, 2012, 53 (04): : 408 - +
  • [43] Structural analysis of obscurin gene in hypertrophic cardiomyopathy
    Arimura, Takuro
    Matsumoto, Yuji
    Okazaki, Osamu
    Hayashi, Takeharu
    Takahashi, Megumi
    Inagaki, Natsuko
    Hinohara, Kunihiko
    Ashizawa, Naoto
    Yano, Keisuke
    Kimura, Akinorl
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (02) : 281 - 287
  • [44] Reversible transition from a hypertrophic to a dilated cardiomyopathy
    Spillmann, Frank
    Kuehl, Uwe
    Van Linthout, Sophie
    Dominguez, Fernando
    Escher, Felicitas
    Schultheiss, Heinz-Peter
    Pieske, Burkert
    Tschoepe, Carsten
    ESC HEART FAILURE, 2016, 3 (02): : 138 - 142
  • [45] Genomic Context Predicts Dilated but Not Hypertrophic Cardiomyopathy
    Puckelwartz, Megan J.
    Pesce, Lorenzo L.
    Dellefave-Castillo, Lisa M.
    Wheeler, Matthew T.
    Pottinger, Tess D.
    Robinson, Avery C.
    Gacita, Anthony M.
    Schoppen, Zachary J.
    Pan Wenyu
    Kim, Gene
    Wilcox, Jane E.
    Anderson, Allen S.
    Ashley, Euan A.
    Day, Sharlene M.
    Cappola, Thomas
    Dorn, Gerald W., II
    McNally, Elizabeth M.
    CIRCULATION RESEARCH, 2019, 125
  • [46] Histopathological differences between hypertrophic and dilated cardiomyopathy
    Tsiviltidou, P.
    Chatzifotiou, E.
    Nikolaou, A.
    Dimitriadis, I.
    Tagarakis, G.
    Anestakis, D.
    VIRCHOWS ARCHIV, 2017, 471 : S307 - S307
  • [47] SUDDEN-DEATH IN HYPERTROPHIC AND DILATED CARDIOMYOPATHY
    KOGA, Y
    OGATA, M
    KIHARA, K
    TSUBAKI, K
    TOSHIMA, H
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1989, 53 (12): : 1546 - 1556
  • [48] THE ROLE OF THE ICD IN PATIENTS WITH DILATED AND HYPERTROPHIC CARDIOMYOPATHY
    BORGGREFE, M
    CHEN, X
    BLOCK, M
    HAVERKAMP, W
    HINDRICKS, G
    SHENASA, M
    BREITHARDT, G
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (04): : 616 - 626
  • [49] Melting heart: dilated phase of hypertrophic cardiomyopathy
    Canpolat, Ugur
    Sahiner, Levent
    Kaya, Ergun Baris
    Aytemir, Kudret
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2012, 12 (07): : E36 - E37
  • [50] Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
    Nomura, Seitaro
    Ono, Minoru
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10